Cargando…

New Rheumatoid Arthritis Treatments for ‘Old’ Patients: Results of a Systematic Review

INTRODUCTION: In the last 20 years, biologic and targeted synthetic disease-modifying antirheumatic drugs (DMARDs) have become available for treating rheumatoid arthritis (RA), and a treat-to-target strategy has been introduced. We hypothesise that these advances should have resulted in changes to t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caporali, Roberto, Fakhouri, Walid K. H., Nicolay, Claudia, Longley, Harriet J., Losi, Serena, Rogai, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444401/ https://www.ncbi.nlm.nih.gov/pubmed/32705531 http://dx.doi.org/10.1007/s12325-020-01435-6

Ejemplares similares

Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings
por: Perrone, Valentina, et al.
Publicado: (2021)

Real-World Analysis of Therapeutic Patterns in Patients Affected by Rheumatoid Arthritis in Italy: A Focus on Baricitinib
por: Perrone, Valentina, et al.
Publicado: (2020)

Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
por: Fakhouri, Walid, et al.
Publicado: (2018)

A Network Meta-Analysis to Compare Effectiveness of Baricitinib and Other Treatments in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate
por: Fakhouri, Walid, et al.
Publicado: (2020)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018)

Rheumatoid arthritis treatment: the earlier the better to prevent joint damage
por: Monti, Sara, et al.
Publicado: (2015)

Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment
por: Bobbio-Pallavicini, Francesca, et al.
Publicado: (2004)

Costs associated with rheumatoid arthritis in Italy: past, present, and future
por: Benucci, Maurizio, et al.
Publicado: (2016)

Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs
por: Favalli, Ennio Giulio, et al.
Publicado: (2014)

Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
por: Bertoldi, Ilaria, et al.
Publicado: (2021)

Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective
por: Bugatti, Serena, et al.
Publicado: (2012)

The role of extracellular vesicles in rheumatoid arthritis: a systematic review
por: Schioppo, Tommaso, et al.
Publicado: (2021)

B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
por: Bugatti, Serena, et al.
Publicado: (2014)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
por: Bugatti, Serena, et al.
Publicado: (2016)

Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
por: Fakhouri, Walid, et al.
Publicado: (2021)

The Draining Lymph Node in Rheumatoid Arthritis: Current Concepts and Research Perspectives
por: Benaglio, Francesca, et al.
Publicado: (2015)

Rheumatoid arthritis: the old issue, the new therapeutic approach
por: Babaahmadi, Mahnaz, et al.
Publicado: (2023)

Performance of the 2010 Classification Criteria for Rheumatoid Arthritis: A Systematic Literature Review and a Meta-Analysis
por: Sakellariou, Garifallia, et al.
Publicado: (2013)

The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis
por: Cavagna, Lorenzo, et al.
Publicado: (2013)

Atherosclerosis and Rheumatoid Arthritis: More Than a Simple Association
por: Cavagna, Lorenzo, et al.
Publicado: (2012)

Methotrexate and Rheumatoid Arthritis: Current Evidence Regarding Subcutaneous Versus Oral Routes of Administration
por: Bianchi, Gerolamo, et al.
Publicado: (2016)

The impact of disease severity and duration on cost, early retirement and ability to work in rheumatoid arthritis in Europe: an economic modelling study
por: Galloway, James, et al.
Publicado: (2020)

COVID-19 infection and rheumatoid arthritis: Faraway, so close!
por: Favalli, Ennio Giulio, et al.
Publicado: (2020)

Erratum in: Cost per responder for upadacitinib vs abatacept in patients with moderate-to-severe Rheumatoid Arthritis in Italy
por: Caporali, Roberto, et al.
Publicado: (2022)

Olive Oil and Nuts in Rheumatoid Arthritis Disease Activity
por: De Vito, Roberta, et al.
Publicado: (2023)

Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review
por: Orsini, Francesco, et al.
Publicado: (2023)

Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis—going beyond treat to target
por: Taylor, Peter C., et al.
Publicado: (2021)

Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis: results of a 12-month open-label randomised study
por: Montecucco, Carlomaurizio, et al.
Publicado: (2012)

Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis
por: Fautrel, Bruno, et al.
Publicado: (2018)

Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors
por: Manzo, Antonio, et al.
Publicado: (2016)

Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis: An Integrated Analysis
por: Tanaka, Yoshiya, et al.
Publicado: (2018)

Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib
por: Combe, Bernard, et al.
Publicado: (2019)

The Link Between Autonomic Nervous System and Rheumatoid Arthritis: From Bench to Bedside
por: Ingegnoli, Francesca, et al.
Publicado: (2020)

Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence
por: Iannone, Florenzo, et al.
Publicado: (2022)

Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies
por: Haraoui, Boulos, et al.
Publicado: (2019)

Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Patel, Jalpa, et al.
Publicado: (2023)

Long-term treatment with low dose glucocorticoids in Rheumatoid Arthritis: New tricks of an old drug
por: Nikas, Spyros N.
Publicado: (2018)

Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis
por: Crepaldi, Gloria, et al.
Publicado: (2016)

Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure
por: Scirè, Carlo Alberto, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ha9jll87b6qqtq6c3p0t0v1qr9